Results 31 to 40 of about 81,795 (214)

Middle East Respiratory Syndrome Coronavirus Antibodies in Bactrian and Hybrid Camels from Dubai

mSphere, 2020
So far, dromedary camels are the only known animal reservoir for Middle East respiratory syndrome (MERS) coronavirus (MERS-CoV). Previous published serological studies showed that sera of Bactrian camels were all negative for MERS-CoV antibodies. However,
Susanna K. P. Lau, Kenneth S. M. Li, Hayes K. H. Luk, Zirong He, Jade L. L. Teng, Kwok-Yung Yuen, Ulrich Wernery, Patrick C. Y. Woo   +7 more
doaj   +1 more source

Scanning Electron Microscopic Findings on Respiratory Organs of Some Naturally Infected Dromedary Camels with the Lineage-B of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Saudi Arabia—2018

Pathogens, 2021
The currently known animal reservoir for MERS-CoV is the dromedary camel. The clinical pattern of the MERS-CoV field infection in dromedary camels is not yet fully studied well.
Abdelmohsen Alnaeem, Samy Kasem, Ibrahim Qasim, Mohamed Refaat, Ali Nasser Alhufufi, Ali Al-Doweriej, Abdulkareem Al-Shabebi, Abd-El Rahman Taha Hereba, Maged Gomaa Hemida   +8 more
doaj   +1 more source

The middle east respiratory syndrome coronavirus respiratory infection: an emerging infection from the arabian peninsula [PDF]

, 2016
This article is made available for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source.
Al-Tawfiq, J. A., Memish, Ziad A.
core   +1 more source

The impact of co-infection of influenza A virus on the severity of Middle East Respiratory Syndrome Coronavirus [PDF]

, 2017
This article is made available for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source.
Al-Tawfiq, Jaffar A., Alfaraj, Sarah H., Altwaijri, Talal A., Alzahrani, Nojoom A., Memish, Ziad A.   +4 more
core   +1 more source

CD8+ T Cells Responding to the Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Delivered by Vaccinia Virus MVA in Mice

Viruses, 2018
Middle East respiratory syndrome coronavirus (MERS-CoV), a novel infectious agent causing severe respiratory disease and death in humans, was first described in 2012.
Svenja Veit, Sylvia Jany, Robert Fux, Gerd Sutter, Asisa Volz   +4 more
doaj   +1 more source

[Middle East Respiratory Syndrome Coronavirus (MERS-CoV) – Camel virus and zoonotic pathogen]

Berliner und Münchener Tierärztliche Wochenschrift, 2021
The Middle East Respiratory Syndrome Coronavirus (MERS-CoV) has been firstly identified in September 2012 as causative agent of severe and lethal respiratory disease in humans (Table 1).
Christian Meyer zu Natrup, Asisa Volz
doaj   +1 more source

Influenza is more common than Middle East Respiratory Syndrome Coronavirus (MERS-CoV) among hospitalized adult Saudi patients [PDF]

, 2017
Background Since the initial description of Middle East Respiratory Syndrome Coronavirus (MERS-CoV), we adopted a systematic process of screening patients admitted with community acquired pneumonia.
Al-Tawfiq, Jaffar A., Hinedi, Kareem, Rabaan, Ali A.   +2 more
core   +1 more source

Replication of MERS and SARS coronaviruses in bat cells offers insights to their ancestral origins

Emerging Microbes and Infections, 2018
Previous findings of Middle East Respiratory Syndrome coronavirus (MERS-CoV)-related viruses in bats, and the ability of Tylonycteris-BatCoV HKU4 spike protein to utilize MERS-CoV receptor, human dipeptidyl peptidase 4 hDPP4, suggest a bat ancestral ...
Susanna K. P. Lau, Rachel Y. Y. Fan, Hayes K. H. Luk, Longchao Zhu, Joshua Fung, Kenneth S. M. Li, Emily Y. M. Wong, Syed Shakeel Ahmed, Jasper F. W. Chan, Raven K. H. Kok, Kwok-Hung Chan, Ulrich Wernery, Kwok-Yung Yuen, Patrick C. Y. Woo   +13 more
doaj   +1 more source

Anti-S1 MERS-COV IgY Specific Antibodies Decreases Lung Inflammation and Viral Antigen Positive Cells in the Human Transgenic Mouse Model

Vaccines, 2020
The Middle East respiratory syndrome coronavirus (MERS-CoV) was identified in 2012 and causes severe and often fatal acute respiratory illness in humans. No approved prophylactic and therapeutic interventions are currently available.
Aymn T. Abbas, Sherif A. El-Kafrawy, Sayed Sartaj Sohrab, Ashraf A. Tabll, Ahmed M. Hassan, Naoko Iwata-Yoshikawa, Noriyo Nagata, Esam I. Azhar   +7 more
doaj   +1 more source

Virtual Screening and Inhibition of Middle East Respiratory Syndrome Coronavirus Replication by Targeting Papain-like Protease

Dr. Sulaiman Al Habib Medical Journal, 2021
Infection by the emerging, potentially zoonotic Middle East Respiratory Syndrome Coronavirus (MERS-CoV) presents a severe health hazard to humans and is often fatal.
Mahmoud Kandeel, Byoung Kwon Park, Mohamed A. Morsy, Katharigatta N. Venugopala, Kentaro Oh-hashi, Mohammed Al-Nazawi, Hyung-Joo Kwon   +6 more
doaj   +1 more source